Literature DB >> 17143954

Effects of huoxiangzhengqi liquid on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrhea.

Yin-Hui He1, Hong-Yan Zhao, Zhen-Li Liu, Cheng Lu, Xiao-Jian Luo, Se-Qi Lin, Xing-Wen Qian, Shi-Lin Chen, Ai-Ping Lu.   

Abstract

AIM: To explore effects of huoxiangzhengqi liquid (HXZQ) on enteric mucosal immune responses in mice with Bacillus dysenteriae and Salmonella typhimurium induced diarrhea (BSD).
METHODS: BSD was induced in Balb/c mice by oral administration with Bacillus dysenteriae and Salmonella typhimurium. HXZQ was administrated from the day of diarrhea induction at dosages of 5.21 g/kg and 0.52 g/kg, respectively. The onset of diarrhea and lasting time were recorded. Peyer's patches and peripheral lymphocytes were prepared for flow cytometry, and levels of TNF-alpha in peripheral blood and enteric tissue homogenates were determined with ELISA. Student's t test was employed for statistics.
RESULTS: Mice in BSD group started showing continuous diarrhea on the day of induction until the fourth day when they were sacrificed. Diarrhea in the mice of HXZQ high and low dose groups lasted for 36 and 54 h, respectively. There were more CD4+ and CD8+ cells in peripheral blood, fewer CD4+ cells in Peyer's patches in BSD mice compared to normal mice. Fewer CD4+ and CD8+ cells was shown in the mice in HXZQ high group compared to BSD mice. In Peyer's patch, there were more CD8+ cells in mice in HXZQ high and low dose groups and more CD4+ in mice in HXZQ high group. Higher levels of TNF-alpha in peripheral blood and intestinal tissue homogenates in BSD group were observed. Mice in HXZQ high group showed decreased levels of TNF-alpha in peripheral blood and enteric tissue homogenates.
CONCLUSION: The immune regulation of CD4+ and CD8+ cells in Peyer's patch and suppression of TNF-alpha levels in enteric homogenates may partially explain the effect of HXZQ on improvement of BSD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143954      PMCID: PMC4087496          DOI: 10.3748/wjg.v12.i45.7346

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Anti-TNF agents in Crohn's disease.

Authors:  G Van Assche; P Rutgeerts
Journal:  Expert Opin Investig Drugs       Date:  2000-01       Impact factor: 6.206

2.  [Quality control for huoxiang-zhengqi liquid].

Authors:  Z Wu; L Kuang; G Zhang; Z Pan; F Li; X Hu
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  1998-04

Review 3.  Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces.

Authors:  Francesca Granucci; Paola Ricciardi-Castagnoli
Journal:  Curr Opin Microbiol       Date:  2003-02       Impact factor: 7.934

Review 4.  Microbial/host interactions: mechanisms involved in host responses to microbial antigens.

Authors:  Suzanne M Michalek; Jannet Katz; Noel K Childers; Michael Martin; Daniel F Balkovetz
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 5.  Immunogenetic phenotypes in inflammatory bowel disease.

Authors:  Marla-C Dubinsky; Kent Taylor; Stephan-R Targan; Jerome-I Rotter
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

6.  Bovine viral diarrhea virus type 1- and type 2-specific bovine T lymphocyte-subset responses following modified-live virus vaccination.

Authors:  Janice J Endsley; Mark J Quade; Brett Terhaar; James A Roth
Journal:  Vet Ther       Date:  2002

7.  Prebiotics in infant milk formulas: new perspectives.

Authors:  V L Miniello; G E Moro; L Armenio
Journal:  Acta Paediatr Suppl       Date:  2003-09

Review 8.  Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.

Authors:  George Kollias; Dimitris Kontoyiannis
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

Review 9.  Mucosal immunity--mucosal tolerance. A strategy for treatment of allergic diseases.

Authors:  Ursula Wiedermann
Journal:  Chem Immunol Allergy       Date:  2003

10.  Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.

Authors:  J McCarthy; L O'Mahony; L O'Callaghan; B Sheil; E E Vaughan; N Fitzsimons; J Fitzgibbon; G C O'Sullivan; B Kiely; J K Collins; F Shanahan
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more
  12 in total

1.  Effect of herbal extract granules combined with probiotic mixture on irritable bowel syndrome with diarrhea: study protocol for a randomized controlled trial.

Authors:  Seok-Jae Ko; Bongha Ryu; Jinsung Kim; Beom-Gi Hong; Inkwon Yeo; Beom-Joon Lee; Jin-Moo Lee; Jae-Woo Park
Journal:  Trials       Date:  2011-10-06       Impact factor: 2.279

2.  Protective effect of huoxiang zhengqi oral liquid on intestinal mucosal mechanical barrier of rats with postinfectious irritable bowel syndrome induced by acetic Acid.

Authors:  Yao Liu; Wei Liu; Qiu-Xian Peng; Jiang-Li Peng; Lin-Zhong Yu; Jian-Lan Hu
Journal:  Evid Based Complement Alternat Med       Date:  2014-08-28       Impact factor: 2.629

3.  Coptidis rhizome and Si Jun Zi Tang can prevent Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Chiung-Hung Chang; Bi Yu; Chiu-Hsian Su; Daniel S Chen; Yu-Chi Hou; Yueh-Sheng Chen; Yuan-Man Hsu
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 4.  Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.

Authors:  Chang Li; Lin Wang; Linzhu Ren
Journal:  Virus Res       Date:  2020-06-24       Impact factor: 3.303

5.  Effect of feeding Chinese herb medicine ageratum-liquid on intestinal bacterial translocations induced by H9N2 AIV in mice.

Authors:  Haoran Lu; Luxuan Zhang; Junfang Xiao; Che Wu; Huanmin Zhang; Yihu Chen; Zhengyong Hu; Wencheng Lin; Qingmei Xie; Hongxin Li
Journal:  Virol J       Date:  2019-02-21       Impact factor: 4.099

Review 6.  The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence.

Authors:  Dan Zhang; Bing Zhang; Jin-Tao Lv; Ri-Na Sa; Xiao-Meng Zhang; Zhi-Jian Lin
Journal:  Pharmacol Res       Date:  2020-05-05       Impact factor: 7.658

7.  The potential insights of Traditional Chinese Medicine on treatment of COVID-19.

Authors:  Tong Tong; Ying-Qi Wu; Wei-Jian Ni; Ai-Zong Shen; Sheng Liu
Journal:  Chin Med       Date:  2020-05-24       Impact factor: 5.455

Review 8.  Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.

Authors:  Wei Zhuang; Zheng Fan; Yanqi Chu; Haizheng Wang; Ying Yang; Li Wu; Nan Sun; Ge Sun; Yuqiao Shen; Xiaolan Lin; Guiming Guo; Shengyan Xi
Journal:  Front Pharmacol       Date:  2020-07-17       Impact factor: 5.810

9.  Systems Pharmacology Dissection of Multi-Scale Mechanisms of Action of Huo-Xiang-Zheng-Qi Formula for the Treatment of Gastrointestinal Diseases.

Authors:  Miaoqing Zhao; Yangyang Chen; Chao Wang; Wei Xiao; Shusheng Chen; Shuwei Zhang; Ling Yang; Yan Li
Journal:  Front Pharmacol       Date:  2019-01-11       Impact factor: 5.810

10.  Nitrate Is Crucial for the Proliferation of Gut Escherichia coli Caused by H9N2 AIV Infection and Effective Regulation by Chinese Herbal Medicine Ageratum-Liquid.

Authors:  Xinheng Zhang; Qiqi Zhao; Che Wu; Zi Xie; Xiaotong Ci; Hongxin Li; Wencheng Lin; Huanmin Zhang; Qingmei Xie
Journal:  Front Microbiol       Date:  2020-10-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.